ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026
Free water changes and their correlations with multimodal biomarkers in frontotemporal dementia.
Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
introductionThe alterations of free water (FW) in behavioral variant frontotemporal dementia (bvFTD) and its clinical correlations remain unclear.
methodsFW levels in the whole brain and specific white matter fiber tract was evaluated in 112 bvFTD patients and 103 normal controls.
resultsBvFTD patients exhibited elevated FW in the whole brain and regional white matter tracts, especially in the uncinate fasciculus and cingulum hippocampus. FW was correlated with perivascular spaces (PVSs) and diffusion tensor imaging analysis along the perivascular space (DTI-ALPS) index. FW was also correlated with clinical scales, gray matter volume, and glucose metabolism. Additionally, FW was correlated with plasma glial fibrillary acidic protein and total tau. Mediation analyses showed that FW mediated the association between PVS and ALPS, and brain neurodegeneration mediated the association between FW and clinical scores. DISCUSSION: Elevated FW is involved in bvFTD and contributes to glymphatic dysfunction and neurodegeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.